EXTRANEAL Drug Patent Profile

✉ Email this page to a colleague

When do Extraneal patents expire, and what generic alternatives are available?

Extraneal is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in EXTRANEAL is icodextrin. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the icodextrin profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for EXTRANEAL?
What are the global sales for EXTRANEAL?
What is Average Wholesale Price for EXTRANEAL?

Summary for EXTRANEAL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	14
Clinical Trials:	11
Drug Prices:	Drug price information for EXTRANEAL
What excipients (inactive ingredients) are in EXTRANEAL?	EXTRANEAL excipients list
DailyMed Link:	EXTRANEAL at DailyMed

Drug patent expirations by year for EXTRANEAL

Recent Clinical Trials for EXTRANEAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
First Affiliated Hospital, Sun Yat-Sen University	Phase 4
Iperboreal Pharma Srl	Phase 3
Baxter Healthcare Corporation	N/A

See all EXTRANEAL clinical trials

Pharmacology for EXTRANEAL

Drug Class	Blood Coagulation Factor Calculi Dissolution Agent Osmotic Laxative Phosphate Binder
Mechanism of Action	Magnesium Ion Exchange Activity Osmotic Activity Phosphate Chelating Activity
Physiological Effect	Increased Coagulation Factor Activity Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Inhibition Small Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion

US Patents and Regulatory Information for EXTRANEAL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for EXTRANEAL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	⤷ Sign Up	⤷ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	⤷ Sign Up	⤷ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	⤷ Sign Up	⤷ Sign Up
Baxter Hlthcare	EXTRANEAL	icodextrin	SOLUTION;INTRAPERITONEAL	021321-001	Dec 20, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for EXTRANEAL

See the table below for patents covering EXTRANEAL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Austria	53765		⤷ Sign Up
Denmark	288586		⤷ Sign Up
Norway	159768		⤷ Sign Up
Austria	38778		⤷ Sign Up
Norway	850603		⤷ Sign Up
United Kingdom	8610841		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for EXTRANEAL

Recent Clinical Trials for EXTRANEAL

Pharmacology for EXTRANEAL

Make Better Decisions: Try a trial or see plans & pricing